THC

Tenet Healthcare Corporation
NYSEHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$21.34B
P/E Ratio
10.25
EPS
$25.87
Beta
1.23
52W High
$283.05
52W Low
$157.58
50-Day MA
$237.69
200-Day MA
$208.25
Dividend Yield
Profit Margin
10.30%
Forward P/E
12.61
PEG Ratio
1.83

About Tenet Healthcare Corporation

Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$21.81B
Gross Profit (TTM)$9.09B
EBITDA$4.84B
Operating Margin18.20%
Return on Equity37.30%
Return on Assets8.32%
Revenue/Share (TTM)$252.49
Book Value$57.86
Price-to-Book4.55
Price-to-Sales (TTM)0.98
EV/Revenue1.427
EV/EBITDA5.79
Quarterly Earnings Growth (YoY)213.40%
Quarterly Revenue Growth (YoY)6.80%
Shares Outstanding$80.52M
Float$79.66M
% Insiders0.97%
% Institutions102.05%

Historical Volatility

HV 10-Day
24.58%
HV 20-Day
25.98%
HV 30-Day
36.60%
HV 60-Day
50.84%
HV Rank
43.7%

Volatility is currently contracting

Analyst Ratings

Consensus ($285.10 target)
5
Strong Buy
14
Buy
3
Hold

Latest News

Fast-paced Momentum Stock Tenet (THC) Is Still Trading at a Bargain

Tenet (THC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks Investment Research9/4/2026Positive
Should Value Investors Buy Tenet Healthcare (THC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research8/31/2026Positive
Tenet (THC) Is Considered a Good Investment by Brokers: Is That True?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Zacks Investment Research8/20/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on THC and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 9/7/2026